The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Virchow Biotech Private Limited (part of the Virchow Group), a vaccine and pharmaceutical producers in India, has announced the agreement to produce in the country up to 200 million doses per year of Sputnik V, a registered vaccine against coronavirus. The technology transfer is […]
about people, work, and workplaces